LDL cholesterol estimation in patients with the metabolic syndrome
Open Access
- 6 April 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 5 (1), 8
- https://doi.org/10.1186/1476-511x-5-8
Abstract
Background The Friedewald formula (LDL-F) for the estimation of low-density lipoprotein (LDL) cholesterol concentrations is the most often used formula in clinical trials and clinical practice. However, much concern has been raised as to whether this formula is applicable in all patient populations such as the presence of chylomicronaemia and/or hypertriglyceridaemia. The aim of the present study was to evaluate various LDL cholesterol calculation formulas as well as LDL cholesterol levels provided by the Lipoprint LDL System (LDL-L) in patients with the metabolic syndrome (MetSyn). Results LDL-F showed significant differences from other formulas in the total cohort, as well as in MetSyn individuals. This was not the case in nonMetSyn subjects, where LDL-F did not differ with other formulas, with the exception of one formula (LDL by Planella, LDL-P). The bias between LDL-F and other LDL estimation formulas were significantly higher in MetSyn subjects compared to nonMetSyn individuals, except for LDL-L which produced similar bias with LDL-F in both study groups. Conclusion LDL-F seems to exhibit some limitations as far as the calculation of LDL-C levels in patients with the MetSyn is concerned. LDL-L might be more accurate in MetSyn subjects, but so far its use is limited for the estimation of small, dense LDL (sdLDL) cholesterol levels and mean LDL particle size for research purposes only.Keywords
This publication has 27 references indexed in Scilit:
- Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human PlasmaClinical Chemistry, 2005
- Management of high triglycerides: what non-specialists in lipids need to know.2005
- The prevalence of the metabolic syndrome in Greece: The MetS‐Greece Multicentre StudyDiabetes, Obesity and Metabolism, 2004
- Metabolic Syndrome: Clinical Features Leading to Therapeutic StrategiesVascular Disease Prevention, 2004
- Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patientsClinical Biochemistry, 2004
- High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective studyThe Lancet, 2001
- Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patientsClinical Biochemistry, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in MenCirculation, 1997
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJama-Journal Of The American Medical Association, 1986